Navigation Links
Informed Medical Communications Appoints New Chief Financial Officer
Date:5/27/2008

EDISON, N.J., May 27 /PRNewswire/ -- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Bert Marchio to the position of Executive Vice President/Chief Financial Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080512/NYM105LOGO )

Marchio brings to IMC over 20 years of experience in senior financial leadership positions in both the public and private sectors, with the last 15 years spent in the pharmaceutical industry. Most recently, he served as Vice President, Treasurer of MedPointe where he helped lead the financial turnaround and eventual sale of the company. During his tenure, the value of MedPointe shares doubled and the company saw a dramatic improvement in cash flow. Prior to this, Marchio helped finance the domestic and international growth of Alpharma from under $300MM in sales (1992) to approximately $1.3B (2005) while building treasury, tax, risk management and benefit finance systems as their Vice President, Treasurer. Marchio holds a BA in Economics from Muhlenberg College, an MBA in Professional Accounting from Rutgers Graduate School of Business and a Post-MBA Certificate in Taxation from Bernard Baruch College.

"Bert has tremendous experience in the financial and pharmaceutical realms, which will be invaluable to us as we continue to grow the IMC business," said Steve Budd, CEO of IMC. "We are equally excited by the fact that the tremendous potential of IMC has attracted someone of Bert's caliber in this critical role."

About Informed Medical Communications

Informed Medical Communications (http://www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting general and specialty peer-to-peer medical programs, respectively. Additionally, IMC's major businesses are enhanced by MRxHealth, the market research and consulting infrastructure that supports IMC's ongoing development and effectiveness of non-traditional marketing programs for biopharmaceutical clients, and Leading Through Dialogue, a communications training service for elite skill development in three areas: (1) leadership, (2) sales, and (3) training/facilitation. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company.


'/>"/>
SOURCE Informed Medical Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors
2. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
3. Informed Medical Communications Hires New Vice President of Marketing
4. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
5. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
6. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
7. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
8. BioMS Medical announces its intention to renew a normal course issuer bid
9. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
10. ATS Medical Expands Open Pivot Heart Valve Offerings
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... April 26, 2017  Genisphere LLC, provider of ... signed a collaborative and sponsored research agreement with ... Muro . The overall goal of the partnership ... various 3DNA designs and formulations after in ... of the vasculature as well as inflammatory responses, ...
(Date:4/25/2017)... 25, 2017 Providence ... its novel immune-modulating technology to an undisclosed global pharmaceutical ... Tregitopes, pronounced TĀ·rejĀ·itopes, are a set ... EpiVax CEO Annie De Groot and ... G, an autoimmune disease therapy, Tregitopes are capable ...
(Date:4/24/2017)... ... April 24, 2017 , ... It is well established that ... the broad application of this cellular target engagement concept to drug discovery has ... thermal stabilization assays are valuable methods for particular applications, but they can require ...
(Date:4/21/2017)... Conn. (PRWEB) , ... April 21, 2017 , ... ... (CI) and Webster Bank, today announced first round funding to three startups through ... provide early-stage financial support to new business startups affiliated with UConn. , The ...
Breaking Biology Technology:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/7/2017)... BRIGHTON, England , March 7, 2017 Brandwatch ... been chosen by The Prince,s Trust to uncover insights ... insights across The Trust. The UK,s leading youth charity ... track social campaign results and get a better understanding of the ... ...
Breaking Biology News(10 mins):